These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 16397743)

  • 1. Fit-for-purpose method development and validation for successful biomarker measurement.
    Lee JW; Devanarayan V; Barrett YC; Weiner R; Allinson J; Fountain S; Keller S; Weinryb I; Green M; Duan L; Rogers JA; Millham R; O'Brien PJ; Sailstad J; Khan M; Ray C; Wagner JA
    Pharm Res; 2006 Feb; 23(2):312-28. PubMed ID: 16397743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method validation and measurement of biomarkers in nonclinical and clinical samples in drug development: a conference report.
    Lee JW; Weiner RS; Sailstad JM; Bowsher RR; Knuth DW; O'Brien PJ; Fourcroy JL; Dixit R; Pandite L; Pietrusko RG; Soares HD; Quarmby V; Vesterqvist OL; Potter DM; Witliff JL; Fritche HA; O'Leary T; Perlee L; Kadam S; Wagner JA
    Pharm Res; 2005 Apr; 22(4):499-511. PubMed ID: 15846456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fit-for-purpose biomarker method validation in anticancer drug development.
    Cummings J; Ward TH; Dive C
    Drug Discov Today; 2010 Oct; 15(19-20):816-25. PubMed ID: 20708097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical biomarker validation.
    Allinson JL
    Bioanalysis; 2018 Jun; 10(12):957-968. PubMed ID: 29923754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of fit-for-purpose biomarker validations: an LBA perspective.
    Neely RJ
    Bioanalysis; 2018 Jun; 10(12):905-907. PubMed ID: 29923756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Method validation and application of protein biomarkers: basic similarities and differences from biotherapeutics.
    Lee JW
    Bioanalysis; 2009 Nov; 1(8):1461-74. PubMed ID: 21083095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker method validation in anticancer drug development.
    Cummings J; Ward TH; Greystoke A; Ranson M; Dive C
    Br J Pharmacol; 2008 Feb; 153(4):646-56. PubMed ID: 17876307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.
    Valentin MA; Ma S; Zhao A; Legay F; Avrameas A
    J Pharm Biomed Anal; 2011 Jul; 55(5):869-77. PubMed ID: 21530130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis.
    Lee JW; Hall M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1259-71. PubMed ID: 19038585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of commercial biomarker kits and proposal for 'drug development kits' to support bioanalysis: call for action.
    Islam R; Kar S; Islam C; Farmen R
    Bioanalysis; 2018 Jun; 10(12):945-955. PubMed ID: 29939797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical issues in the validation of prognostic, predictive, and surrogate biomarkers.
    Sargent DJ; Mandrekar SJ
    Clin Trials; 2013 Oct; 10(5):647-52. PubMed ID: 23983158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.
    Jani D; Allinson J; Berisha F; Cowan KJ; Devanarayan V; Gleason C; Jeromin A; Keller S; Khan MU; Nowatzke B; Rhyne P; Stephen L
    AAPS J; 2016 Jan; 18(1):1-14. PubMed ID: 26377333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in drug discovery and development: from target identification through drug marketing.
    Colburn WA
    J Clin Pharmacol; 2003 Apr; 43(4):329-41. PubMed ID: 12723454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategic approach to fit-for-purpose biomarkers in drug development.
    Wagner JA
    Annu Rev Pharmacol Toxicol; 2008; 48():631-51. PubMed ID: 17937595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAPS and US FDA Crystal City VI workshop on bioanalytical method validation for biomarkers.
    Lowes S; Ackermann BL
    Bioanalysis; 2016 Feb; 8(3):163-7. PubMed ID: 26795584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational medicine--a paradigm shift in modern drug discovery and development: the role of biomarkers.
    Day M; Rutkowski JL; Feuerstein GZ
    Adv Exp Med Biol; 2009; 655():1-12. PubMed ID: 20047030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of pharmacokinetic/pharmacodynamic biomarkers to support rational cancer drug development.
    Sarker D; Pacey S; Workman P
    Biomark Med; 2007 Oct; 1(3):399-417. PubMed ID: 20477383
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.